Daiichi Sankyo Co. Ltd. | Mutual Funds
Mutual Funds that own Daiichi Sankyo Co. Ltd.
American Funds Capital World Growth & Income Fund
21,749,700
3.07%
0
0.95%
06/30/2018
American Funds EuroPacific Growth Fund
13,886,000
1.96%
-7,120,000
0.38%
06/30/2018
American Funds Investment Company of America
13,618,000
1.92%
13,618,000
0.57%
06/30/2018
Nomura Asset NIKKEI 225 Index ETF (1321)
9,444,000
1.33%
128,000
0.71%
07/31/2018
Nomura Asset TOPIX ETF Fund (1306)
9,037,100
1.27%
143,100
0.49%
07/31/2018
Vanguard Total International Stock Index Fund
9,012,069
1.27%
117,000
0.1%
07/31/2018
Government Pension Fund - Global (The)
8,994,689
1.27%
-50,898
0.04%
12/31/2017
Nikko Asset Listed Index 225 ETF (1330)
4,790,000
0.68%
2,000
0.7%
08/20/2018
Daiwa Asset TOPIX Listed ETF (1305)
4,435,700
0.63%
105,800
0.5%
07/31/2018
Daiwa Asset NIKKEI 225 ETF (1320)
4,228,000
0.6%
-16,000
0.7%
07/31/2018
| Address |
Daiichi Sankyo Head Office Bldg, A&B
Tokyo Tokyo 103
Japan
|
|
Employees
|
- |
| Website |
http://www.daiichisankyo.co.jp |
| Updated |
07/08/2019 |
| Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. |
